27 C
Vientiane
Thursday, November 6, 2025
spot_img

Cision PR Newswire

Riyadh Opens Its Doors to the World: Biban 2025 Kicks Off as the Global Destination for Opportunities

RIYADH, Saudi Arabia, Nov. 6, 2025 /PRNewswire/ -- The Small and Medium Enterprises General Authority (Monsha'at) in Saudi Arabia inaugurated Biban Forum 2025 today at the Riyadh Front Exhibition & Conference Center, marking the start of the Kingdom's largest annual gathering for startups, entrepreneurs, and small and medium enterprises...

Delta Force Reveals Big Plans for 2025 Updates

New Release Windows for Mobile Version Announced Los Angeles, Jan. 13, 2025 /PRNewswire/ -- Today, Delta Force developer Team Jade revealed their plans for continuing...

Luzerne’s Craftsmanship Helps Dehua Ceramic Trade Association (China) Secure Guinness World Records Title for Largest Porcelain Car Sculpture (supported)

SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Luzerne Pte Ltd is proud to announce its crucial role in helping the Dehua Ceramic Trade Association (China)...

Gianna Lullume Baby Soother Device Officially Launches on Kickstarter

HONG KONG, Jan. 13, 2025 /PRNewswire/ -- Gianna Lullume, an innovative brand committed to improving infant sleep and promoting family well-being, is proud to...

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc....

LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025

Exhibition booth attracts 65,000 cumulative visitors, showcasing innovative mobility components Innovative technologies presented through a 'User-Centric storytelling' approach elicit strong acclaim, inquiries from...

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine

- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine - Based on the Excellent Safety and Immune Response in...